Oncoinvent AS is a privately held Norwegian company that designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns
Oncoinvent has raised €3.7M across 1 funding round from 1 investor, most recently a Early VC round in May 2020. Based in Oslo, Norway; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-27 | Early VC |
| €3.7M |
| Hadean Ventures |
| View deal → |
